{'fraction_non_alphanumeric': 0.0486646884272997, 'fraction_numerical': 0.049851632047477744, 'mean_word_length': 4.833910034602076, 'pattern_counts': {'":': 0, '<': 1, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Review of Investigation and Management of Severe Hyponatremia in a Hospital Population

The purpose of this study was to assess retrospectively the prevalence of severe hyponatremia in a hospital population and its laboratory investigation, treatment and clinical outcome. Over a 6-month period 47 patients (27 women and 20 men) were found to have a plasma sodium concentration of ≤ 120 mmol/L (this number made up less than 0·17% of all plasma sodium requests over that time period). The mean patient age was 75±16 years and the average hospital stay was 37±45 days (1–179 days). Patient mortality was 51% (women 57% and men 43%). The mean initial plasma sodium concentration was 116±4·5 mmol/L, rising after therapeutic intervention to a mean of 130±4·2 mmol/L. The mean plasma sodium correction rate was 4·7±4·3 mmol/L/24 h (0·9–17·5 range). Twelve per cent of the patients had their plasma sodium raised at a rate of greater than 10 mmol/L/24h after their initial presentation. Two patients may have had symptoms and signs suggestive of cerebral oedema/cortical dysfunction: in one patient the sodium concentration was raised at a rate of 9·5 mmol/L/24 h and in the other at 12·0 mmol/L/24h. Sixty-one per cent of the patients had a chest infection, 44% were on diuretics, 28% had congestive cardiac failure, 28% were post-operative (9% orthopaedic procedures), 19% had carcinoma and 9% were on a selective serotonin re-uptake inhibitor. Regarding laboratory investigations, 56% had liver function tests, 41% had thyroid function tests, 36% had plasma osmolality determination, 36% had urinary electrolytes including urinary osmolality and < 2% had tests to exclude hypoadrenalism.